Skip to main content

Lab Notes: Code Bio makes potential $2B deal; Marinus suffers Covid-related setback

The Center for Breakthrough Medicines has formed a cell and gene therapy partnership with a Philadelphia CRO.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.